Key points
The impact of a multi-modal infection control strategy originally designed for containment of COVID-19 on the rates of other hospital-acquired-infections (HAIs) was evaluated over an 7-month period across the largest healthcare system in Singapore.
During the COVID-19 pandemic, MRSA acquisition rates declined significantly, together with central-line-associated-bloodstream infection (CLABSI) rates; likely due to increased compliance with standard precautions.
Enhanced infection control measures resulted in the unintended positive consequences of containing healthcare-associated respiratory viral infections, with a significant and sustained decline for both enveloped and non-enveloped respiratory viruses.
The ongoing COVID-19 pandemic provided the impetus to demonstrate the potential benefit of heightened infection control measures in controlling HAIs and acquisition of MDROs